ESR1 and breast cancer: AURKA promotes distant metastases in ERα-positive breast cancer cells [33, 72] and its overexpression is strongly linked to decreased survival, high nuclear grade, and elevated HER-2/neu and progesterone receptor levels in breast cancer [73, 74].